Live Quote · NASDAQRYZBHealthcare· Biotechnology

RayzeBio, Inc. Common Stock

$62.49▲ 0.02%(+$0.01)
MKT CAP $3.75BLAST EARNINGS Mar 4, 2024
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
80
Valuation
30
Profitability
15
Growth
68
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RYZB research report →

Analyst RatingHold
0 Buy1 Hold0 Sell

Price Chart

+160.38% · this period
$62.49$40.45$18.42Sep 15Dec 08Mar 06
52-Week Range100% of range
Low
$17.95
Current
$62.49
High
$62.51